Cancer clinical trials in the region Occitanie
306 currently recruiting clinical trials
Looking for clinical trials?
Clinical trial search is a complex process, with countless criteria to consider. Our AI assistant navigates this complexity with precise, expert-level analysis of the most relevant trials based on your medical profile. Our database is fully up to date, so you see only actively recruiting sites. It's fast and easy:
- Create your account
- Copy-paste your latest medical report
- Our AI-based assistant does the rest for you
Whether you are a patient or a doctor, create an account to find and apply for the most relevant clinical trials:
Early Access
Lung cancer
NSCLC (Non-Small Cell Lung Cancer)
Non-squamous NSCLC
Locally Advanced
EGFR
None
Chemotherapy
Radiotherapy
AstraZeneca
Early Access
Lymphoma
B cell lymphoma
Large B cell lymphoma
2
3 or more
Systemic Treatment-Naive
Hoffmann-La Roche
Early Access
Lung cancer
SCLC (Small Cell Lung Cancer)
Localized
Locally Advanced
None
Chemotherapy
Radiotherapy
Chemotherapy
Radiotherapy
AstraZeneca
Early Access
Lung cancer
NSCLC (Non-Small Cell Lung Cancer)
Locally Advanced
Metastatic
EGFR
None
Systemic Treatment-Naive
Janssen
Early Access
Lung cancer
NSCLC (Non-Small Cell Lung Cancer)
Locally Advanced
Metastatic
EGFR
1
Targeted therapy
Systemic Treatment-Naive
Janssen
Early Access
Lymphoma
B cell lymphoma
Large B cell lymphoma
1
Systemic Treatment-Naive
Hoffmann-La Roche
Phase 3
Lung cancer
#NCT06119581
#2023-503412-33-00
NSCLC (Non-Small Cell Lung Cancer)
Locally Advanced
Metastatic
KRAS G12C
None
Systemic Treatment-Naive
BRAF
EGFR
HER2
MET
NTRK-1/2/3
RET
ROS-1
Immunotherapy
Chemotherapy
Targeted therapy
Hôpital Larrey (Toulouse )
Eli Lilly et compagnie
Phase 3
Breast cancer
#NCT06382948
HER2 Negative
HR Positive
Locally Advanced
Metastatic
ESR
1
2
Targeted therapy
Hormone therapy
ESR
Systemic Treatment-Naive
Chemotherapy
IUCT Oncopôle (Toulouse)
MedSIR
Phase 3
Lung cancer
#NCT06881784
#2024-518154-16-00
NSCLC (Non-Small Cell Lung Cancer)
Locally Advanced
Metastatic
Other KRAS
HRAS
KRAS G12C
KRAS non G12C
KRAS G12D
NRAS
1
2
Immunotherapy
Chemotherapy
Systemic Treatment-Naive
Hôpital Larrey (Toulouse ), Institut du cancer de Montpellier (Montpellier)
Revolution Medicines, Inc.
Phase 3
Stomach and esophageal cancer
#NCT06901531
#2024-519773-19-00
Stomach
Oesogastric junction
Adenocarcinoma
Locally Advanced
Metastatic
Claudin 18.2
None
Systemic Treatment-Naive
CPS Positive (1 <= X < 5)
CPS Positive (5 <= X < 10)
CPS Positive (X >= 10)
HER2
Immunotherapy
Chemotherapy
Centre Hospitalier de Carcassonne (Carcassonne), Institut du cancer de Montpellier (Montpellier)
Astellas Pharma Développement mondial, Inc.